Skip to content
OpenCapital
Get started

Citius Oncology, Inc. CTOR Gross margin

Gross margin at other companies

Merck & Co. logo
Merck & Co.MRK
73.9%-2.5pp
Delcath Systems logo
Delcath SystemsDCTH
86%+1.1pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
36.7%+4.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
99.3%-0.5pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
100%+31.2pp
Gilead Sciences logo
Gilead SciencesGILD
79.4%+1.1pp

Other financials

Income statement

See full
Revenue$1.7M—
Gross profit$1.3M—
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×